A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2011
12/13/2011	US8076100 Genetic engineering; vaccine; induction antibodies
12/13/2011	US8076096 Alteration of cell membrane with FasL
12/13/2011	US8075928 Method for fermentation and cultivation, fermented plant extract, fermented plant extract powder, and composition containing the extract of fermented plant
12/13/2011	US8075898 Mite allergen
12/13/2011	US8075897 Allergen peptide fragments and use thereof
12/13/2011	US8075896 Method to enhance an immune response of nucleic acid vaccination
12/13/2011	CA2539070C Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
12/13/2011	CA2476008C Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
12/13/2011	CA2441048C Novel compound for treatment of allergy and asthma
12/13/2011	CA2358520C Soluble receptor br43x2 and methods of using
12/13/2011	CA2267851C Bordetella strain expressing the fha hybrid, liposomes and vaccines
12/13/2011	CA2229203C Antigenic preparations from keratinophilic fungi
12/08/2011	WO2011153493A2 Biodegradable lipids for the delivery of active agents
12/08/2011	WO2011153277A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
12/08/2011	WO2011152671A2 Pharmaceutical composition for the prevention or treatment of inflammatory diseases or immune diseases containing ramalin
12/08/2011	WO2011152503A1 Treatment drug for autoimmune diseases and allergic diseases
12/08/2011	WO2011152485A1 Novel 4,5-fused pyrimidine derivative
12/08/2011	WO2011152351A1 Purinone derivative
12/08/2011	WO2011152330A1 Soybean protein hydrolysate-containing antioxidant and use thereof
12/08/2011	WO2011152297A1 Solid dispersion comprising triazole compound
12/08/2011	WO2011151941A1 Composition having activity of inducing proliferation or accumulation of regulatory t cell
12/08/2011	WO2011151449A1 Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
12/08/2011	WO2011151431A1 Oral vaccine comprising an antigen and a toll-like receptor agonist
12/08/2011	WO2011113895A3 Characterization and validation of inhibitors and ligands of dipeptidyl aminopeptidase iv (dp iv)
12/08/2011	WO2011103666A8 Modulation of cytokine-induced chronic inflammatory responses
12/08/2011	WO2011100460A3 Ccr7 ligand delivery and co-delivery in immunotherapy
12/08/2011	WO2011097527A9 Immunoprotection of therapeutic moieties using enhanced fc regions
12/08/2011	US20110301697 Manufacture, method and use of drug-eluting medical devices for permanently keeping blood vessels open
12/08/2011	US20110301217 Selective Glycosidase Inhibitors and Uses Thereof
12/08/2011	US20110301177 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
12/08/2011	US20110301168 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
12/08/2011	US20110301165 Method for treating and preventing arthritis
12/08/2011	US20110301161 Benzimidazole inhibitors of leukotriene production
12/08/2011	US20110301160 Inhibitors of P38 and Methods of Using the Same
12/08/2011	US20110301157 Bicyclic amides as kinase inhibitors
12/08/2011	US20110301149 Compositions and methods for treating alcohol use disorders, pain and other diseases
12/08/2011	US20110301145 Pyridazinones, method of making, and method of use thereof
12/08/2011	US20110301144 Kinase Antagonists
12/08/2011	US20110301134 Alkyne antagonists of lysophosphatidic acid receptors
12/08/2011	US20110301128 Pyrrole Derivatives As Pharmaceutical Agents
12/08/2011	US20110301125 Method for Treating Macular Degeneration
12/08/2011	US20110301104 Transition state structure of orotate phosphoribosyl transferases and uses thereof
12/08/2011	US20110301101 T cell immune balance peptides
12/08/2011	US20110301097 Oral Administration Of Therapeutic Agent Coupled To Transporting Agent
12/08/2011	US20110301096 Prodrug of an ice inhibitor
12/08/2011	US20110300226 Peptide particle formulation
12/08/2011	US20110300223 Immunogenic composition
12/08/2011	US20110300205 Self replicating rna molecules and uses thereof
12/08/2011	US20110300186 Functionalized Nano- and Micro-materials for Medical Therapies
12/08/2011	US20110300185 Immunogenic escherichia coli heat stable enterotoxin
12/08/2011	US20110300183 Method of preparing adenosine-resistant anti-tumor t lymphocytes for adoptive immunotherapy
12/08/2011	US20110300182 Nucleic acid drug for treatment of allergic disease
12/08/2011	US20110300181 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
12/08/2011	US20110300179 Novel Compositions and Uses Thereof
12/08/2011	US20110300178 Hpv types and variants associated with cervical cancer and the uses thereof
12/08/2011	US20110300177 Triterpene saponins, methods of synthesis, and uses thereof
12/08/2011	US20110300173 Capsule composition for use as immunogen against Campylobacter jejuni
12/08/2011	US20110300172 Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
12/08/2011	US20110300171 Factor h binding protein immunogens
12/08/2011	US20110300170 Hcv vaccines
12/08/2011	US20110300169 Pharmaceutical composition comprising an antigen
12/08/2011	US20110300167 Cxcr5 receptor compounds
12/08/2011	US20110300166 Vaccine Compositions for Inducing Immune Responses Against Components of Drusen
12/08/2011	US20110300165 Substituted isoxazole compounds
12/08/2011	US20110300164 Immunostimulatory dna:rna oligonucleotides
12/08/2011	US20110300163 IgE CH3 Peptide Vaccine
12/08/2011	US20110300154 Treatment of airway hyperreactivity
12/08/2011	US20110300152 Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
12/08/2011	US20110300149 Ljungan virus
12/08/2011	US20110300148 Il-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases
12/08/2011	US20110300145 Interferon Alpha Antibodies And Their Uses
12/08/2011	US20110300144 Methods and compositions for diagnosis and treatment of cancer
12/08/2011	US20110300142 Use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants
12/08/2011	US20110300141 Novel Alphabeta-Binding protein and its peptide derivatives and uses thereof
12/08/2011	US20110300136 Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor
12/08/2011	US20110300129 Systems and methods for enhancing vaccine efficacy
12/08/2011	US20110300119 Methods of enriching and using regulatory t cells
12/08/2011	US20110300118 Agents for promoting iga production
12/08/2011	US20110300105 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
12/08/2011	US20110300069 Methods of Using Labeled Ligands Having Human CD4 Specificity
12/08/2011	US20110300067 Methods for increasing efficacy of radioimmunotherapy of melanoma
12/08/2011	US20110300066 Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases
12/08/2011	CA2801585A1 Peptide particle formulation
12/08/2011	CA2801554A1 Nasal immunization
12/08/2011	CA2801509A1 Treatment drug for autoimmune diseases and allergic diseases
12/08/2011	CA2801266A1 Oral vaccine comprising an antigen and a toll-like receptor agonist
12/08/2011	CA2801125A1 Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
12/08/2011	CA2800882A1 Conjugates for the prevention or treatment of nicotine addiction
12/08/2011	CA2800531A1 Humanized monoclonal antibodies and methods of use
12/08/2011	CA2800523A1 Purinone derivative
12/08/2011	CA2800401A1 Biodegradable lipids for the delivery of active agents
12/07/2011	EP2392597A2 Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
12/07/2011	EP2392594A1 N-terminally monopegylated polypeptides and process for their preparation
12/07/2011	EP2392579A1 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
12/07/2011	EP2392352A2 Cd93 or use of soluble fragment thereof
12/07/2011	EP2392350A1 Methods for treating conditions associated with MASP-2 dependent complement activation
12/07/2011	EP2392336A2 Use of 24-norUDCA
12/07/2011	EP2392320A1 Treatment of inflammatory diseases
12/07/2011	EP2391649A1 Tslp promotes immune evasion and persistence of viruses
12/07/2011	EP2391605A1 Scriptaid isosteres and their use in therapy

1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 1172